BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.49% -14.47% -20.30% -6.07% -4.31% -1.10% -4.38% -4.22% 13.18% 04/07/2010
BIB NAV -1.28% -14.31% -20.40% -5.95% -4.14% -1.07% -4.38% -4.22% 13.19% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 6/05/2025
  • NAV
    $45.16
  • NAV Change
    $-0.05 down caret
  • Market Price
    $45.21
  • Market Price Change
    $-0.04 down caret
  • Trading Volume (M)
    12,598
  • 30-Day Median Bid Ask Spread
    0.28%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 6/05/2025
  • NAV
    $45.16
  • NAV Change
    $-0.05 down caret
  • Market Price
    $45.21
  • Market Price Change
    $-0.04 down caret
  • Trading Volume (M)
    12,598
  • 30-Day Median Bid Ask Spread
    0.28%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2025

Holdings

as of 6/05/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.13% GILD GILEAD SCIENCES INC -- $2,850,530.76 25,806 2369174
5.91% AMGN AMGEN INC -- $2,749,269.60 9,576 2023607
5.87% VRTX VERTEX PHARMACEUTICALS INC -- $2,728,605.36 6,148 2931034
4.11% REGN REGENERON PHARMACEUTICALS -- $1,910,541.85 3,955 2730190
3.33% AZN ASTRAZENECA PLC-SPONS ADR -- $1,549,809.35 21,421 2989044
3.15% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,466,696.00 4,762 B00FWN1
1.51% BIIB BIOGEN INC -- $701,988.60 5,385 2455965
1.47% ARGX ARGENX SE - ADR -- $683,935.02 1,178 BDVLM39
1.16% RPRX ROYALTY PHARMA PLC- CL A -- $537,975.00 15,940 BMVP7Y0
1.15% SMMT SUMMIT THERAPEUTICS INC -- $535,393.28 27,136 BMTVQS7
1.14% UTHR UNITED THERAPEUTICS CORP -- $528,160.92 1,652 2430412
1.13% SNY SANOFI-ADR -- $525,963.20 10,570 2964557
1.04% INSM INSMED INC -- $484,302.92 6,658 2614487
1.03% ILMN ILLUMINA INC -- $479,270.75 5,827 2613990
1.03% INCY INCYTE CORP -- $478,681.56 7,119 2471950
0.98% NBIX NEUROCRINE BIOSCIENCES INC -- $457,069.48 3,668 2623911
0.94% EXEL EXELIXIS INC -- $436,241.52 10,296 2576941
0.87% BNTX BIONTECH SE-ADR -- $403,149.00 3,660 BK6H543
0.85% ONC BEONE MEDICINES LTD-ADR -- $395,523.00 1,539 BYYWPW6
0.85% ASND ASCENDIS PHARMA A/S - ADR -- $394,516.10 2,222 BV9G6B8
0.83% BMRN BIOMARIN PHARMACEUTICAL INC -- $387,884.86 7,018 2437071
0.80% VTRS VIATRIS INC -- $371,487.06 43,911 BMWS3X9
0.80% MRNA MODERNA INC -- $370,721.16 14,193 BGSXTS3
0.78% TEM TEMPUS AI INC -- $360,700.34 6,149 BSLSJJ0
0.71% MEDP MEDPACE HOLDINGS INC -- $329,103.18 1,121 BDCBC61
0.65% BPMC BLUEPRINT MEDICINES CORP -- $300,692.90 2,351 BWY52P3
0.63% ROIV ROIVANT SCIENCES LTD -- $293,988.80 26,249 BMW4NZ9
0.59% RVMD REVOLUTION MEDICINES INC -- $274,927.80 6,839 BL71K91
0.58% BBIO BRIDGEBIO PHARMA INC -- $268,226.64 6,996 BK1KWG8
0.53% VRNA VERONA PHARMA PLC - ADR -- $247,980.46 2,899 BYWPZK5
0.52% JAZZ JAZZ PHARMACEUTICALS PLC -- $243,059.20 2,234 B4Q5ZN4
0.52% HALO HALOZYME THERAPEUTICS INC -- $242,581.50 4,530 2975098
0.48% MDGL MADRIGAL PHARMACEUTICALS INC -- $222,569.20 812 BD59BS7
0.47% GH GUARDANT HEALTH INC -- $219,781.40 4,540 BFXC911
0.44% IONS IONIS PHARMACEUTICALS INC -- $206,083.52 5,848 BDJ0LS6
0.43% AXSM AXSOME THERAPEUTICS INC -- $198,524.04 1,794 BYZR4X4
0.41% NUVL NUVALENT INC-A -- $190,071.06 2,434 BMVBZD3
0.40% ALKS ALKERMES PLC -- $185,442.00 5,982 B3P6D26
0.37% ADMA ADMA BIOLOGICS INC -- $173,398.24 8,696 B9NSBM2
0.35% PCVX VAXCYTE INC -- $164,847.60 4,737 BKPVGH6
0.34% AKRO AKERO THERAPEUTICS INC -- $157,990.26 2,929 BK7Y2V9
0.34% RNA AVIDITY BIOSCIENCES INC -- $157,378.98 4,422 BMWHPY1
0.33% RYTM RHYTHM PHARMACEUTICALS INC -- $153,934.68 2,326 BF2YWG4
0.32% PTCT PTC THERAPEUTICS INC -- $150,068.73 2,901 B17VCN9
0.31% MRUS MERUS NV -- $142,377.42 2,542 BZBY005
0.30% KRYS KRYSTAL BIOTECH INC -- $140,577.20 1,060 BD6JX35
0.30% SRPT SAREPTA THERAPEUTICS INC -- $139,940.49 3,569 B8DPDT7
0.30% CYTK CYTOKINETICS INC -- $139,740.48 4,356 BBBSBJ5
0.29% ACLX ARCELLX INC -- $133,891.25 2,021 BPCJ1Q2
0.28% ACAD ACADIA PHARMACEUTICALS INC -- $130,920.90 6,135 2713317
0.28% SWTX SPRINGWORKS THERAPEUTICS INC -- $129,027.60 2,757 BGMGM89
0.27% RARE ULTRAGENYX PHARMACEUTICAL IN -- $125,604.73 3,403 BJ62Z18
0.26% CRSP CRISPR THERAPEUTICS AG -- $121,688.35 3,155 BDHF4K6
0.26% PTGX PROTAGONIST THERAPEUTICS INC -- $121,525.56 2,258 BDCBCD8
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $119,292.75 3,483 BFZQ0L8
0.25% ALVO ALVOTECH SA -- $116,445.00 11,090 BPNTJ34
0.24% KYMR KYMERA THERAPEUTICS INC -- $113,859.74 2,389 BMPRZV5
0.24% CRNX CRINETICS PHARMACEUTICALS IN -- $110,631.36 3,423 BDD19F8
0.22% IMVT IMMUNOVANT INC -- $100,108.98 6,249 BJRFSB7
0.20% LEGN LEGEND BIOTECH CORP-ADR -- $94,597.40 3,005 BMX9K07
0.19% APLS APELLIS PHARMACEUTICALS INC -- $88,184.70 4,617 BYTQ6X1
0.19% XENE XENON PHARMACEUTICALS INC -- $86,535.68 2,816 BRJ3GY4
0.18% BCRX BIOCRYST PHARMACEUTICALS INC -- $84,403.26 7,687 2100362
0.18% ZLAB ZAI LAB LTD-ADR -- $84,078.54 2,301 BD9GVY0
0.18% AMRX AMNEAL PHARMACEUTICALS INC -- $81,752.34 11,402 BFNF1D6
0.17% MIRM MIRUM PHARMACEUTICALS INC -- $80,503.95 1,803 BJDX8Y8
0.17% VCEL VERICEL CORP -- $79,769.20 1,838 BSBMN89
0.17% -- NEWAMSTERDAM PHARMA CO NV -- $78,820.40 4,040 BP8JSP4
0.17% IBRX IMMUNITYBIO INC -- $77,894.00 26,860 BNSP0B8
0.17% VCYT VERACYTE INC -- $77,351.66 2,867 BFTWZY0
0.16% ARWR ARROWHEAD PHARMACEUTICALS IN -- $76,357.94 4,639 BYQBFJ8
0.16% DNLI DENALI THERAPEUTICS INC -- $75,963.24 5,342 BD2B4V0
0.16% CGON CG ONCOLOGY INC -- $74,590.63 2,801 BRBCSP4
0.16% HRMY HARMONY BIOSCIENCES HOLDINGS -- $73,913.30 2,110 BKSGZN7
0.16% LGND LIGAND PHARMACEUTICALS -- $73,759.44 708 2501578
0.15% VERA VERA THERAPEUTICS INC -- $71,827.35 2,345 BL55460
0.15% AGIO AGIOS PHARMACEUTICALS INC -- $70,786.64 2,108 BCBVTX1
0.15% IDYA IDEAYA BIOSCIENCES INC -- $67,942.00 3,220 BK0VHF6
0.14% FOLD AMICUS THERAPEUTICS INC -- $67,359.92 11,302 B19FQ48
0.14% TWST TWIST BIOSCIENCE CORP -- $66,544.02 2,194 BGKG6G7
0.14% NVCR NOVOCURE LTD -- $66,507.35 4,043 BYSS4X4
0.14% RXRX RECURSION PHARMACEUTICALS-A -- $66,415.81 14,533 BM9FJ13
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $66,394.02 2,053 B72ZBG4
0.13% APGE APOGEE THERAPEUTICS INC -- $62,348.40 1,656 BM9HHL5
0.13% TARS TARSUS PHARMACEUTICALS INC -- $62,240.96 1,412 BMH5RL1
0.13% INDV INDIVIOR PLC -- $62,065.53 4,567 BP0BQQ5
0.13% IRON DISC MEDICINE INC -- $61,068.72 1,272 BMGJZJ8
0.13% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $58,957.64 4,364 BKX9VD3
0.13% DYN DYNE THERAPEUTICS INC -- $58,212.39 4,161 BN15WD1
0.12% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $55,433.16 1,458 BLCD809
0.12% JANX JANUX THERAPEUTICS INC -- $53,828.24 2,174 BMFX8Y7
0.12% ADPT ADAPTIVE BIOTECHNOLOGIES -- $53,584.23 5,429 BJ5FZ74
0.11% ETNB 89BIO INC -- $53,485.20 5,370 BK1K484
0.11% BEAM BEAM THERAPEUTICS INC -- $52,343.00 3,079 BK6L288
0.11% EWTX EDGEWISE THERAPEUTICS INC -- $51,618.06 3,483 BKY5JZ8
0.11% OCUL OCULAR THERAPEUTIX INC -- $48,924.18 5,783 BNZB1X8
0.10% INVA INNOVIVA INC -- $48,818.02 2,306 BDDXF67
0.10% GRAL GRAIL INC -- $48,809.64 1,236 BSLSSX7
0.10% SPRY ARS PHARMACEUTICALS INC -- $48,048.00 3,575 BMCR7V2
0.10% TVTX TRAVERE THERAPEUTICS INC -- $48,046.08 3,264 BLFGJD5
0.10% MNKD MANNKIND CORP -- $48,022.40 11,168 BF081J4
0.10% ANIP ANI PHARMACEUTICALS INC -- $47,963.88 801 BCDWBX6
0.10% GPCR STRUCTURE THERAPEUTICS INC -- $47,062.24 2,192 BQS9486
0.10% KNSA KINIKSA PHARMACEUTICALS INTE -- $45,608.40 1,545 BRXB0C0
0.10% PCRX PACIRA BIOSCIENCES INC -- $45,511.48 1,702 B3X26D8
0.10% DVAX DYNAVAX TECHNOLOGIES CORP -- $45,411.80 4,564 BRJZSK0
0.10% AMPH AMPHASTAR PHARMACEUTICALS IN -- $45,144.88 1,769 BNFWZS4
0.09% NVAX NOVAVAX INC -- $41,359.83 5,917 BJDQXG4
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $40,870.68 5,052 BFWLC09
0.09% CNTA CENTESSA PHARMACEUTICALS-ADR -- $39,825.88 3,358 BLB0YQ9
0.08% GRFS GRIFOLS SA-ADR -- $39,135.36 4,488 B8K7T65
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $38,401.89 1,797 BMFD115
0.08% WVE WAVE LIFE SCIENCES LTD -- $37,874.25 5,611 BYZG9R0
0.08% HROW HARROW INC -- $37,623.20 1,310 BHNDW86
0.08% SYRE SPYRE THERAPEUTICS INC -- $36,846.54 2,217 BQBBDY8
0.08% CVAC CUREVAC NV -- $36,808.38 8,253 BN4RD42
0.08% GERN GERON CORP -- $36,549.24 23,429 2370381
0.08% TXG 10X GENOMICS INC-CLASS A -- $36,276.02 3,982 BKS3RS7
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $35,042.40 3,140 BN7Q7R7
0.08% NRIX NURIX THERAPEUTICS INC -- $34,900.00 2,792 BMVLGP2
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $34,161.00 1,158 BX7RSN3
0.07% GMAB GENMAB A/S -SP ADR -- $33,631.02 1,542 BBC9WC7
0.07% AVDL AVADEL PHARMACEUTICALS -- $33,464.80 3,545 BDGMC59
0.07% QURE UNIQURE NV -- $33,037.29 1,989 BJFSR88
0.07% ARDX ARDELYX INC -- $31,915.52 8,768 BN89V40
0.07% PRAX PRAXIS PRECISION MEDICINES I -- $31,356.92 742 BQ721R4
0.07% ZYME ZYMEWORKS INC -- $30,737.42 2,534 BPCQZY9
0.07% LENZ LENZ THERAPEUTICS INC -- $30,663.60 1,012 BQV0J03
0.06% CRMD CORMEDIX INC -- $29,417.76 2,232 BJ0LT31
0.06% AVBP ARRIVENT BIOPHARMA INC -- $29,102.80 1,240 BMGTLY5
0.06% NTLA INTELLIA THERAPEUTICS INC -- $28,864.64 3,808 BYZM6C2
0.06% MLYS MINERALYS THERAPEUTICS INC -- $28,631.46 1,833 BP9N0G0
0.06% REPL REPLIMUNE GROUP INC -- $27,621.75 2,833 BDDVW37
0.06% VIR VIR BIOTECHNOLOGY INC -- $25,981.75 5,045 BK4PZ38
0.06% ABCL ABCELLERA BIOLOGICS INC -- $25,979.94 10,962 BL53SR3
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $25,909.60 3,728 BLB0YH0
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $25,088.40 1,818 BD06CS0
0.05% COGT COGENT BIOSCIENCES INC -- $25,086.12 4,188 BLR6XK8
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $24,458.64 5,484 BLR7H87
0.05% AVXL ANAVEX LIFE SCIENCES CORP -- $24,343.62 3,129 BYTYP72
0.05% ORIC ORIC PHARMACEUTICALS INC -- $23,935.08 2,613 BKVDFF7
0.05% ANAB ANAPTYSBIO INC -- $23,845.92 1,128 BDRW1L7
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $23,701.40 6,971 BZ0QMB7
0.05% XNCR XENCOR INC -- $23,639.04 2,592 BGCYWN8
0.05% EOLS EVOLUS INC -- $22,684.46 2,329 BDRJH21
0.05% KROS KEROS THERAPEUTICS INC -- $22,544.12 1,492 BM7V485
0.05% TRVI TREVI THERAPEUTICS INC -- $22,154.38 3,287 BJH9ZN0
0.05% TSHA TAYSHA GENE THERAPIES INC -- $21,718.08 7,541 BNC1BX1
0.05% IOVA IOVANCE BIOTHERAPEUTICS INC -- $21,709.80 12,061 BF0DMK7
0.05% STOK STOKE THERAPEUTICS INC -- $21,194.24 1,948 BJQ05Z6
0.05% SANA SANA BIOTECHNOLOGY INC -- $20,943.15 8,213 BMFJJ97
0.04% MNMD MIND MEDICINE MINDMED INC -- $20,747.62 2,698 BPQYY97
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $20,715.75 2,511 BMGS7L1
0.04% RLAY RELAY THERAPEUTICS INC -- $20,204.64 6,236 BN2R582
0.04% KURA KURA ONCOLOGY INC -- $19,519.47 2,971 BYZD465
0.04% TBPH THERAVANCE BIOPHARMA INC -- $19,482.93 1,809 BMNDK09
0.04% TYRA TYRA BIOSCIENCES INC -- $18,926.37 1,861 BMVNDH9
0.04% CGEM CULLINAN THERAPEUTICS INC -- $18,808.48 2,152 BM90J52
0.04% VERV VERVE THERAPEUTICS INC -- $18,714.18 3,266 BNKGXX2
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $17,869.72 748 BL95N25
0.04% CSTL CASTLE BIOSCIENCES INC -- $17,853.98 1,049 BKLCWZ3
0.04% TRML TOURMALINE BIO INC -- $17,813.27 943 BQ80NC6
0.04% ARVN ARVINAS INC -- $17,507.60 2,530 BDZ30Q0
0.04% HCM HUTCHMED CHINA-ADR -- $17,411.66 1,141 BYXV9H7
0.04% ZVRA ZEVRA THERAPEUTICS INC -- $17,333.29 1,963 BLFBZ32
0.04% FTRE FORTREA HOLDINGS INC -- $16,896.00 3,300 BRXYZ57
0.04% ORKA ORUKA THERAPEUTICS INC -- $16,785.63 1,377 BKVF0J2
0.04% AUTL AUTOLUS THERAPEUTICS PLC -- $16,660.72 7,372 BFMLGR4
0.04% RAPP RAPPORT THERAPEUTICS INC -- $16,596.18 1,346 BR3T9B6
0.04% PSNL PERSONALIS INC -- $16,429.82 3,247 BJQ0608
0.04% ERAS ERASCA INC -- $16,328.00 10,400 BNLYBF3
0.03% AMLX AMYLYX PHARMACEUTICALS INC -- $15,917.60 3,152 BPCK358
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $15,755.00 2,875 BFYQFJ2
0.03% ALT ALTIMMUNE INC -- $15,468.18 2,833 BFY7DC4
0.03% SIGA SIGA TECHNOLOGIES INC -- $15,446.76 2,627 2107437
0.03% SAGE SAGE THERAPEUTICS INC -- $15,336.36 2,262 BP4GNK9
0.03% RGNX REGENXBIO INC -- $15,240.28 1,823 BZ0G875
0.03% GLPG GALAPAGOS NV-SPON ADR -- $15,042.48 538 B292NQ7
0.03% SVRA SAVARA INC -- $15,024.94 6,313 BYXGN81
0.03% MESO MESOBLAST LTD- SPON ADR -- $14,524.11 1,251 BQS7491
0.03% PGEN PRECIGEN INC -- $14,328.09 10,773 BKM5C84
0.03% TNGX TANGO THERAPEUTICS INC -- $13,959.27 3,977 BP2P6L0
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $13,770.00 1,620 BKDQKM6
0.03% ITOS ITEOS THERAPEUTICS INC -- $13,681.92 1,344 BMWXFT4
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $13,588.56 648 BQD3J33
0.03% NGNE NEUROGENE INC -- $12,514.32 546 BS2F741
0.03% HUMA HUMACYTE INC -- $12,400.46 4,733 BMYTJP4
0.03% TECX TECTONIC THERAPEUTIC INC -- $12,190.35 543 BPBPCG8
0.03% ABSI ABSCI CORP -- $11,999.00 4,225 BN94K69
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $11,973.78 3,354 BYVQJ96
0.03% SLDB SOLID BIOSCIENCES INC -- $11,929.75 2,807 BQHN6C7
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $11,862.36 996 BKC9SX3
0.03% ALMS ALUMIS INC -- $11,795.35 3,521 BPLQG36
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $11,795.35 2,515 BJLKVS6
0.02% OLMA OLEMA PHARMACEUTICALS INC -- $11,497.51 2,731 BMZ4LN0
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $11,323.06 5,218 BMCWKZ2
0.02% TKNO ALPHA TEKNOVA INC -- $11,314.97 1,961 BP7L561
0.02% TRDA ENTRADA THERAPEUTICS INC -- $11,229.96 1,383 BP81RK8
0.02% AURA AURA BIOSCIENCES INC -- $11,211.80 1,838 BP81R42
0.02% TERN TERNS PHARMACEUTICALS INC -- $11,062.50 3,125 BMDJ0C9
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $10,863.94 3,922 BDFKQ07
0.02% ATXS ASTRIA THERAPEUTICS INC -- $10,836.72 2,076 BMYRFN8
0.02% GLUE MONTE ROSA THERAPEUTICS INC -- $10,441.20 2,260 BP7KZP7
0.02% CMPS COMPASS PATHWAYS PLC -- $10,346.52 2,284 BMC3HS7
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $10,074.00 10,074 B4N8MH9
0.02% PRTA PROTHENA CORP PLC -- $10,018.80 1,980 B91XRN2
0.02% ANNX ANNEXON INC -- $9,998.55 3,921 BMVV9R5
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $9,949.77 7,713 BFZNYB7
0.02% AVIR ATEA PHARMACEUTICALS INC -- $9,911.33 3,107 BLN9Z50
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $9,558.33 13,331 BWFZX59
0.02% INZY INOZYME PHARMA INC -- $9,428.37 2,363 BMVLGY1
0.02% VNDA VANDA PHARMACEUTICALS INC -- $9,416.55 2,145 B12W3P6
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $9,359.30 1,730 BL5B6Z1
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $9,243.24 2,364 BYP80F1
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $9,078.99 6,439 BPG5P75
0.02% THRD THIRD HARMONIC BIO INC -- $8,770.82 1,658 BNNPQY8
0.02% AMRN AMARIN CORP PLC -ADR -- $8,733.45 737 BN72KB0
0.02% RNAC CARTESIAN THERAPEUTICS INC -- $8,732.90 935 BQB9HM8
0.02% FHTX FOGHORN THERAPEUTICS INC -- $8,429.52 2,046 BMF7DT9
0.02% ESPR ESPERION THERAPEUTICS INC -- $8,407.68 7,248 BBNBTD2
0.02% YMAB Y-MABS THERAPEUTICS INC -- $8,404.80 1,648 BG31GH0
0.02% MXCT MAXCYTE INC -- $8,342.00 3,880 BKMQF66
0.02% DSGN DESIGN THERAPEUTICS INC -- $8,332.00 2,083 BMFK3H6
0.02% URGN UROGEN PHARMA LTD -- $7,977.28 1,552 BZ7PJQ1
0.02% CRGX CARGO THERAPEUTICS INC -- $7,720.08 1,693 BQHN2F2
0.02% SCPH SCPHARMACEUTICALS INC -- $7,566.51 1,841 BYX2Z16
0.02% OMER OMEROS CORP -- $7,035.60 2,132 B4NB858
0.01% CDXS CODEXIS INC -- $6,886.22 3,047 B5LL2C2
0.01% INBX INHIBRX BIOSCIENCES INC -- $6,870.37 533 BNSP8K3
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $6,658.73 1,703 BKLXFX5
0.01% VYGR VOYAGER THERAPEUTICS INC -- $6,629.70 2,009 BY7RB53
0.01% PRME PRIME MEDICINE INC -- $6,562.00 4,825 BPBJFM7
0.01% ACIU AC IMMUNE SA -- $6,293.74 3,638 BZC0D70
0.01% -- LYELL IMMUNOPHARMA INC COMMON STOCK USD 0.0001 -- $6,154.02 537 --
0.01% OABI OMNIAB INC -- $6,143.76 4,452 BN13S71
0.01% LRMR LARIMAR THERAPEUTICS INC -- $5,773.62 2,347 BMXNGZ6
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $5,659.85 785 B9L5200
0.01% FATE FATE THERAPEUTICS INC -- $5,614.60 4,190 BCZS820
0.01% EDIT EDITAS MEDICINE INC -- $5,466.60 3,037 BZ8FPH3
0.01% ALEC ALECTOR INC -- $5,139.45 3,645 BJ4LDC4
0.01% NMRA NEUMORA THERAPEUTICS INC -- $4,814.42 5,943 BN4JN37
0.01% NKTX NKARTA INC -- $4,750.68 2,596 BK80YJ8
0.01% KYTX KYVERNA THERAPEUTICS INC -- $4,668.72 1,588 BSMLR16
0.01% LXEO LEXEO THERAPEUTICS INC -- $3,976.32 1,216 BQ6C357
0.01% CCCC C4 THERAPEUTICS INC -- $3,838.17 2,611 BKX9NQ0
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,604.79 2,239 BMDWW66
0.01% IRWD IRONWOOD PHARMACEUTICALS INC -- $3,361.48 5,887 B3MZ6K5
0.01% MGNX MACROGENICS INC -- $3,348.05 2,309 BFDV8K0
0.01% BMEA BIOMEA FUSION INC -- $3,265.85 1,333 BNKF6N0
0.01% CLYM CLIMB BIO INC -- $3,066.52 2,473 BMW5LX6
0.01% TCRX TSCAN THERAPEUTICS INC -- $3,034.08 1,806 BNLYBJ7
0.01% PYXS PYXIS ONCOLOGY INC -- $2,713.12 2,188 BLBR8D5
0.01% STRO SUTRO BIOPHARMA INC -- $2,500.10 3,033 BF12XC2
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $1,752.24 894 BMF1LJ7
-- PEPG PEPGEN INC -- $1,708.26 1,203 BMTX3D7
-- MRSN MERSANA THERAPEUTICS INC -- $1,673.56 4,544 BF3NP05
-- APLT APPLIED THERAPEUTICS INC -- $1,557.06 4,280 BJL38Z1
-- IGMS IGM BIOSCIENCES INC -- $1,554.96 1,254 BKS3SM8
-- ACRV ACRIVON THERAPEUTICS INC -- $1,431.25 1,145 BP2TPK4
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,329.90 465 BT7KGT6
-- QTTB Q32 BIO INC -- $824.32 448 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
34.73% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 16,153,791 -- 3,863 --
27.93% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 12,992,449 -- 3,107 --
18.25% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 8,488,790 -- 2,030 --
17.25% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 8,024,625 -- 1,919 --
15.96% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 7,422,464 -- 1,775 --
13.81% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 6,423,045 -- 1,536 --
-- -- TREASURY BILL -- $6,991,094.39 7,000,000 BSNQ2D7
-- -- TREASURY BILL -- $4,492,697.85 4,500,000 BRBYPQ0
-- -- UNITED STATES OF AMERICA BILL ZERO CPN 08/JUL/2025 USD 100 -- $3,985,191.12 4,000,000 --
-- -- TREASURY BILL -- $1,496,864.25 1,500,000 BQ7YG75
-- -- TREASURY BILL -- $748,261.00 750,000 BS60BF1
-- -- NET OTHER ASSETS (LIABILITIES) -- $-4,791,491.49 -4,791,491 --

Index

as of 3/31/2025

  • Total Number of Companies264
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.80 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.